Enantiomeric separation of verapamil and its active metabolite, norverapamil, and simultaneous quantification in human Plasma by LC-ESI-MS-MS

Journal of Chromatographic Science

Volumn 50, Issue 9, 2012, Pages 839-848

  Singhal, Puran ^a   Yadav, Manish ^a   Winter, Serge ^b   Guttikar, Swati ^a   Patel, Dharmesh ^a   Mills, Malcolm ^a   Shrivastav, Pranav S ^c  

^a Veeda Clinical Research India   (India)

^b NOVARTIS PHARMA AG   (Switzerland)

^c GUJARAT UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DERIVATIVE; NORVERAPAMIL; VERAPAMIL;

ADULT; ARTICLE; BLOOD; CHEMISTRY; DRUG STABILITY; ELECTROSPRAY MASS SPECTROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIQUID LIQUID EXTRACTION; MALE; METHODOLOGY; MIDDLE AGED; REGRESSION ANALYSIS; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STEREOISOMERISM; TANDEM MASS SPECTROMETRY;

ADULT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG STABILITY; HUMANS; LEAST-SQUARES ANALYSIS; LIQUID-LIQUID EXTRACTION; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; STEREOISOMERISM; TANDEM MASS SPECTROMETRY; VERAPAMIL;

EID: 84867775568     PISSN: 00219665     EISSN: None     Source Type: Journal    
DOI: 10.1093/chromsci/bms080     Document Type: Article

References (39)

1. Kirsten, R., Nelson, K., Kirsten, D., Heintz, B.; Clinical pharmacokinetics of vasodilators; Clinical Pharmacokinetics, (1998); 34: 457-482.
2. Beck, E., Sieber, W.J., Trejo, R.; Management of cluster headache; American Family Physician, (2005); 71: 717-724. (Pubitemid 40269988)
3. Pagel, P.S., Hettrick, D.A., Lowe, D., Gowrie, P.W., Kersten, J.R., Bosnjak, Z.J. et al.; Cardiovascular effects of verapamil enantiomer combinations in conscious dogs; European Journal of Pharmacology, (1998); 348: 213-221. (Pubitemid 28275585)
4. Karim, A., Piergies, A.; Verapamil stereoisomerism: Enantiomeric ratios in plasma dependent on peak concentrations, oral input rat, or both; Clinical Pharmacology and Therapeutics, (1995); 58: 174-184.
5. Lankford, S.M., Bai, S.A.; Determination of the stereochemical composition of the major metabolites of verapamil in dog urine with enantioselective liquid chromatographic techniques; Journal of Chromatography B, (1995); 663: 91-101.
6. Gupta, S.K., Hwang, S., Atkinson, I., Longstreth, J.; Simultaneous firstorder and capacity-limited elimination kinetics after oral administration of verapamil; Journal of Clinical Pharmacology, (1996); 36: 25-34. (Pubitemid 26058807)
7. Tracy, T.S., Korzekwa, K.R., Gonzalez, F.J., Wainer, I.W.; Cytochrome P450 isoforms involved in metabolism of the enantiomers of verapamil and norverapamil; British Journal of Clinical Pharmacology, (1999); 47: 545-552. (Pubitemid 29199727)
8. Harapat, S.R., Kates, R.E.; Rapid high-pressure liquid chromatographic analysis of Verapamil in blood and plasma; Journal of Chromatography, (1979); 170: 385-390. (Pubitemid 10031300)
9. Rustum, A.M.; Measurement of verapamil in human plasma by reversed-phase high-performance liquid chromatography using a short octyl column; Journal of Chromatography, (1990); 528: 480-486. (Pubitemid 20222618)
10. Shin, H.-S., Oh-Shin, Y.-S., Kim, H.-J., Kang, Y.-K.; Sensitive assay for verapamil in plasma gas-liquid chromatography with nitrogenphosphorous detection; Journal of Chromatography B, (1996); 677: 369-373. (Pubitemid 26106006)
11. Borges, N.C.C., Mendes, G.D., Barrientos-Astigarraga, R.E., Galvinas, P., Oliveira, C.H., Nucci, G.; Verapamil quantification in human plasma by liquid chromatography coupled to tandem mass spectrometry. An application for bioequivalence study; Journal of Chromatography B, (2005); 827: 165-172. (Pubitemid 41570112)
12. Ivanova, V., Zendelovska, D., Stefova, M., Stafilov, T.; HPLC method for determination of verapamil in human plasma after solid phase extraction; Journal of Biochemical and Biophysical Methods, (2008); 70: 1297-1303.
13. Lau-Cam, C.A., Piemontese, D.; Simplified reversed-phase HPLC method with spectrophotometric detection for the assay of verapamil in rat plasma; Journal of Pharmaceutical and Biomedical Analysis, (1998); 16: 1029-1035. (Pubitemid 28139040)
14. Jhee, O.H., Hong, J.W., Om, A.S., Lee, M.H., Lee, W.S., Shaw, L.M. et al.; Direct determination of verapamil in rat plasma by coupled column microbore-HPLC method; Journal of Pharmaceutical and Biomedical Analysis, (2005); 37: 405-410. (Pubitemid 40222316)
15. Rambla-Alegre, M., Gil-Agusti, M.T., Capella-Peiro, M.E., Carda-Broch, S., Esteve-Romero, J.S.; Direct determination of verapamil in urine and serum samples by micellar liquid chromatography and fluorescence detection; Journal of Chromatography B, (2006); 839: 89-94. (Pubitemid 44056043)
16. Garcia, M.A., Aramayona, J.J., Bregante, M.A., Fraile, L.J., Solans, C.; Simultaneous determination of verapamil and norverapamil in biological samples by high-performance liquid chromatography using ultraviolet detection; Journal of Chromatography B, (1997); 693: 377-382. (Pubitemid 27250299)
17. Cheng, Y.-F., Neue, U.D., Bean, L.; Straighforward solid-phase extraction method for the determination of verapamil and its metabolite in plasma in a 96-well extraction plate; Journal of Chromatography A, (1998); 828: 273-281. (Pubitemid 29046425)
18. Cole, S.C., Flanagan, R.J., Johnston, A., Holt, D.W.; Rapid highperformance liquid chromatographic method for the measurement of verapamil and norverapamil in blood plasma or serum; Journal of Chromatography, (1981); 218: 621-629. (Pubitemid 12181089)
19. Hubert, P., Chiap, P., Ceccato, A., Bechet, I., Sibenaler-Dechamps, R., Maes, P. et al.; Determination of verapamil and norverapamil in human plasma by liquid chromatography: Comparison between a liquid-liquid extraction procedure and an automated liquid-solid extraction method for sample preparation; Journal of Pharmaceutical and Biomedical Analysis, (1992); 10: 937-942. (Pubitemid 23080454)
20. Ceccato, A., Chiap, P., Hubert, P., Toussaint, B., Crommen, J.; Automated determination of verapamil and norverapmil in human plasma with on-line coupling of dialysis to high-performance liquid chromatography and fluorescence detection; Journal of Chromatography A, (1996); 750: 351-360. (Pubitemid 26374049)
21. Brandsteterova, E., Wainer, I.W.; Achiral and chiral high-performance liquid chromatography of verapamil and its metabolites in serum samples; Journal of Chromatography B, (1999); 732: 395-404. (Pubitemid 29460856)
22. Sawicki, W.; A validated method for the determination of verapamil and norverapamil in human plasma; Journal of Pharmaceutical and Biomedical Analysis, (2001); 25: 689-695. (Pubitemid 32493927)
23. Unadkat, J.D., Chung, F., Sasongko, L., Whittington, D., Eyal, S., Mankoff, D. et al.; Rapid solid-phase extraction method to quantify [11C]-verapamil, and its [11C]-metabolites, in human and macaque plasma; Nuclear Medicine and Biology, (2008); 35: 911-917.
24. Richter, O., Eichelbaum, M., Schonberger, F., Hofmann, U.; Rapid and highly sensitive method for the determination of verapamil, [2H7]verapamil and metabolites in biological fluids by liquid chromatography-mass spectrometry; Journal of Chromatography B, (2000); 738: 137-147. (Pubitemid 30053101)
25. Mullet, W.M., Walles, M., Levsen, K., Borlak, J., Pawliszyn, J.; Multidimensional on-line sample preparation of verapamil and its metabolites by a molecularly imprinted polymer coupled to liquid chromatography-mass spectrometry; Journal of Chromatography B, (2004); 801: 297-306. (Pubitemid 38130080)
26. Chu, Y.-Q., Wainer, I.W.; Determination of the enantiometers of verapamil and norverapamil in serum using coupled achiral-chiral high-performance liquid chromatography; Journal of Chromatography,(1989); 497: 191-200. (Pubitemid 20027115)
27. Koppel, C., Wagemann, A.; Plasma level monitoring of D,L-verapamil and three of its metabolites by reversed-phase high-performance liquid chromatography; Journal of Chromatography, (1991); 570: 229-234.
28. Oda, Y., Asakawa, N., Kajima, T., Yoshida, Y., Sato, T.; On-line determination and resolution of verapamil enantiomers by highperformance liquid chromatography with column switching; Journal of Chromatography, (1991); 541: 411-418.
29. Fieger, H., Blaschke, G.; Direct determination of the enantiomeric ratio of verapamil, its major metabolite norverapamil and gallopamil in plasma by chiral high-performance liquid chromatography; Journal of Chromatography, (1992); 575: 255-260.
30. Shibukawa, A., Wainer, I.W.; Simultaneous direct determination of the enantiomers of verapamil and norverapamil in plasma using a derivatized amylase high-performance liquid chromatographic chiral stationary phase; Journal of Chromatography, (1992); 574: 85-92.
31. Stagni, G., Gillespie, W.R.; Simultaneous analysis of verapamil and norverapamil enantiomers in human plasma by high-performance liquid chromatography; Journal of Chromatography B, (1995); 667: 349-354.
32. Asafu-Adjaye, E.B., Shiu, G.K.; Solid-phase extraction-highperfomance liquid chromatography determination of verapamil and norverapamil enantiomers in urine; Journal of Chromatography B, (1998); 707: 161-167. (Pubitemid 28198049)
33. Sandstrom, R., Lennernas, H., Ohlen, K., Karlsson, A.; Enantiomeric separation of verapamil and norverapamil using Chiral-AGP as the stationary phase; Journal of Pharmaceutical and Biomedical Analysis, (1999); 21: 43-49. (Pubitemid 29430140)
34. Hedeland, M., Fredricksson, E., Lennernas, H., Bondesson, U.; Simultaneous quantification of the enantiomers of verapamil and its N-demethylated metabolite in human plasma using liquid chromatography-tandem mass spectrometry; Journal of Chromatography B, (2004); 804: 303-311. (Pubitemid 38481705)
35. Mateus, F.H., Lepera, J.S., Marques, M.P., Boralli, V.B., Lanchote, V.L.; Simultaneous analysis of the enantiomers of verapamil and norverapamil in rat plasma by liquid chromatography-tandem mass spectrometry; Journal of Pharmaceutical and Biomedical Analysis, (2007); 45: 762-768. (Pubitemid 350087566)
36. Guidance for Industry: Bioanalytical Method Validation, U.S. Department of Health and Human Services, Food and Drug Administration Centre for Drug Evaluation and Research (CDER), Centre for Veterinary Medicine (CVM) 2001.
37. European Medicines Agency Committee for Medicinal Products for Human Use Guidelines on Validation of Bioanalytical Methods (draft), EMA/CMP/EWP/ 192217/ 2009.
38. FDA Guidance for Industry: Bioavailability Studies for Orally Administered Drug Products-General Considerations, U.S. Department of Health and Human Services, Food and Drug Administration Centre for Drug Evaluation and Research (CEDR), 2000.
39. Rocci, M.L., Jr., Devanarayan, V., Haughey, D.B., Jardieu, P.; Confirmatory reanalysis of incurred bioanalytical samples. AAPS Journal, 9: E336-E343 (2007). (Pubitemid 351816757)